Federated Hermes’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-34
| Closed | -$4.28K | – | 2156 |
|
|
2023
Q1 | $4.28K | Sell |
34
-6
| -15% | -$755 | ﹤0.01% | 1950 |
|
|
2022
Q4 | $12.2K | Sell |
40
-11
| -22% | -$3.37K | ﹤0.01% | 1846 |
|
|
2022
Q3 | $3K | Hold |
51
| – | – | ﹤0.01% | 1934 |
|
|
2022
Q2 | $3K | Sell |
51
-2,120
| -98% | -$125K | ﹤0.01% | 1945 |
|
|
2022
Q1 | $248K | Sell |
2,171
-1,284
| -37% | -$147K | ﹤0.01% | 1565 |
|
|
2021
Q4 | $497K | Buy |
3,455
+9
| +0.3% | +$1.3K | ﹤0.01% | 1481 |
|
|
2021
Q3 | $755K | Buy |
3,446
+10
| +0.3% | +$2.19K | ﹤0.01% | 1380 |
|
|
2021
Q2 | $797K | Buy |
3,436
+10
| +0.3% | +$2.32K | ﹤0.01% | 1380 |
|
|
2021
Q1 | $1.03M | Sell |
3,426
-704
| -17% | -$212K | ﹤0.01% | 1360 |
|
|
2020
Q4 | $1.55M | Sell |
4,130
-869
| -17% | -$327K | ﹤0.01% | 1162 |
|
|
2020
Q3 | $1.54M | Sell |
4,999
-10
| -0.2% | -$3.07K | ﹤0.01% | 1080 |
|
|
2020
Q2 | $1.88M | Buy |
5,009
+563
| +13% | +$212K | ﹤0.01% | 1012 |
|
|
2020
Q1 | $1.01M | Buy |
4,446
+3,068
| +223% | +$700K | ﹤0.01% | 1134 |
|
|
2019
Q4 | $729K | Buy |
+1,378
| New | +$729K | ﹤0.01% | 1358 |
|
|
2018
Q1 | – | Sell |
-9
| Closed | -$16K | – | 2176 |
|
|
2017
Q4 | $16K | Buy |
+9
| New | +$16K | ﹤0.01% | 1803 |
|
|
2015
Q3 | – | Sell |
-1
| Closed | -$1K | – | 2000 |
|
|
2015
Q2 | $1K | Buy |
+1
| New | +$1K | ﹤0.01% | 1897 |
|